My Bibliography

select

Hogan KA, Staal RG, Sonsalla PK. Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations. J Neurochem. 2000 May;74(5):2217-20. doi: 10.1046/j.1471-4159.2000.0742217.x. PubMed PMID: 10800969.

select

Staal RG, Hogan KA, Liang CL, German DC, Sonsalla PK. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium. J Pharmacol Exp Ther. 2000 May;293(2):329-35. PubMed PMID: 10772999.

select

Staal RG, Sonsalla PK. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata. J Pharmacol Exp Ther. 2000 May;293(2):336-42. PubMed PMID: 10773000.

select

Chen JF, Xu K, Petzer JP, Staal R, Xu YH, Beilstein M, Sonsalla PK, Castagnoli K, Castagnoli N Jr, Schwarzschild MA. Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci. 2001 May 15;21(10):RC143. doi: 10.1523/JNEUROSCI.21-10-j0001.2001. PubMed PMID: 11319241; PubMed Central PMCID: PMC6762498.

select

Staal RG, Yang JM, Hait WN, Sonsalla PK. Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Brain Res. 2001 Aug 10;910(1-2):116-25. doi: 10.1016/s0006-8993(01)02674-9. PubMed PMID: 11489261.

select

Chen JF, Steyn S, Staal R, Petzer JP, Xu K, Van Der Schyf CJ, Castagnoli K, Sonsalla PK, Castagnoli N Jr, Schwarzschild MA. 8-(3-Chlorostyryl)caffeine may attenuate MPTP neurotoxicity through dual actions of monoamine oxidase inhibition and A2A receptor antagonism. J Biol Chem. 2002 Sep 27;277(39):36040-4. doi: 10.1074/jbc.M206830200. Epub 2002 Jul 18. PubMed PMID: 12130655.

select

Staal RG, Mosharov E, Sulzer D. Calmodulin inhibitors block quantal catecholamine release and increase acidification of neurosecretory granules in rat adrenal chromaffin cells. Ann N Y Acad Sci. 2002 Oct;971:269-72. doi: 10.1111/j.1749-6632.2002.tb04475.x. PubMed PMID: 12438131.

select

Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, Larsen KE, Staal R, Tieu K, Schmitz Y, Yuan CA, Rocha M, Jackson-Lewis V, Hersch S, Sulzer D, Przedborski S, Burke R, Hen R. Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14524-9. doi: 10.1073/pnas.172514599. Epub 2002 Oct 10. PubMed PMID: 12376616; PubMed Central PMCID: PMC137916.

select

Staal RG, Mosharov EV, Sulzer D. Dopamine neurons release transmitter via a flickering fusion pore. Nat Neurosci. 2004 Apr;7(4):341-6. doi: 10.1038/nn1205. Epub 2004 Feb 29. PubMed PMID: 14990933.

select

Li H, Waites CL, Staal RG, Dobryy Y, Park J, Sulzer DL, Edwards RH. Sorting of vesicular monoamine transporter 2 to the regulated secretory pathway confers the somatodendritic exocytosis of monoamines. Neuron. 2005 Nov 23;48(4):619-33. doi: 10.1016/j.neuron.2005.09.033. PubMed PMID: 16301178.

select

Mosharov EV, Staal RG, Bové J, Prou D, Hananiya A, Markov D, Poulsen N, Larsen KE, Moore CM, Troyer MD, Edwards RH, Przedborski S, Sulzer D. Alpha-synuclein overexpression increases cytosolic catecholamine concentration. J Neurosci. 2006 Sep 6;26(36):9304-11. doi: 10.1523/JNEUROSCI.0519-06.2006. PubMed PMID: 16957086; PubMed Central PMCID: PMC6674515.

select

Staal RGW, Rayport S, Sulzer D. Amperometric Detection of Dopamine Exocytosis from Synaptic Terminals. 2007;. Review. PubMed PMID: 21204391.

select

Staal RG, Hananiya A, Sulzer D. PKC theta activity maintains normal quantal size in chromaffin cells. J Neurochem. 2008 Jun;105(5):1635-41. doi: 10.1111/j.1471-4159.2008.05264.x. Epub 2008 Feb 1. PubMed PMID: 18248621; PubMed Central PMCID: PMC6589162.

select

Gubernator NG, Zhang H, Staal RG, Mosharov EV, Pereira DB, Yue M, Balsanek V, Vadola PA, Mukherjee B, Edwards RH, Sulzer D, Sames D. Fluorescent false neurotransmitters visualize dopamine release from individual presynaptic terminals. Science. 2009 Jun 12;324(5933):1441-4. doi: 10.1126/science.1172278. Epub 2009 May 7. PubMed PMID: 19423778; PubMed Central PMCID: PMC6696931.

select

Zhang H, Gubernator NG, Yue M, Staal RG, Mosharov EV, Pereira D, Balsanek V, Vadola PA, Mukherjee B, Edwards RH, Sulzer D, Sames D. Dopamine release at individual presynaptic terminals visualized with FFNs. J Vis Exp. 2009 Aug 31;(30). doi: 10.3791/1562. PubMed PMID: 19721412; PubMed Central PMCID: PMC3253714.

select

Dale E, Staal RG, Eder C, Möller T. KCa 3.1-a microglial target ready for drug repurposing?. Glia. 2016 Oct;64(10):1733-41. doi: 10.1002/glia.22992. Epub 2016 Apr 28. Review. PubMed PMID: 27121595.

select

Möller T, Bard F, Bhattacharya A, Biber K, Campbell B, Dale E, Eder C, Gan L, Garden GA, Hughes ZA, Pearse DD, Staal RG, Sayed FA, Wes PD, Boddeke HW. Critical data-based re-evaluation of minocycline as a putative specific microglia inhibitor. Glia. 2016 Oct;64(10):1788-94. doi: 10.1002/glia.23007. Epub 2016 Jun 1. Review. PubMed PMID: 27246804.

select

Staal RGW, Khayrullina T, Zhang H, Davis S, Fallon SM, Cajina M, Nattini ME, Hu A, Zhou H, Poda SB, Zorn S, Chandrasena G, Dale E, Cambpell B, Biilmann Rønn LC, Munro G, Mӧller T. Inhibition of the potassium channel K(Ca)3.1 by senicapoc reverses tactile allodynia in rats with peripheral nerve injury. Eur J Pharmacol. 2017 Jan 15;795:1-7. doi: 10.1016/j.ejphar.2016.11.031. Epub 2016 Nov 19. PubMed PMID: 27876619.

select

Gandhi AS, Budac D, Khayrullina T, Staal R, Chandrasena G. Quantitative analysis of lipids: a higher-throughput LC-MS/MS-based method and its comparison to ELISA. Future Sci OA. 2017 Mar;3(1):FSO157. doi: 10.4155/fsoa-2016-0067. eCollection 2017 Mar. PubMed PMID: 28344822; PubMed Central PMCID: PMC5351511.

select

Staal RGW, Weinstein JR, Nattini M, Cajina M, Chandresana G, Möller T. Senicapoc: Repurposing a Drug to Target Microglia K(Ca)3.1 in Stroke. Neurochem Res. 2017 Sep;42(9):2639-2645. doi: 10.1007/s11064-017-2223-y. Epub 2017 Mar 31. Review. PubMed PMID: 28364331; PubMed Central PMCID: PMC8979772.

select

Kurnik M, Sahin C, Andersen CB, Lorenzen N, Giehm L, Mohammad-Beigi H, Jessen CM, Pedersen JS, Christiansen G, Petersen SV, Staal R, Krishnamurthy G, Pitts K, Reinhart PH, Mulder FAA, Mente S, Hirst WD, Otzen DE. Potent α-Synuclein Aggregation Inhibitors, Identified by High-Throughput Screening, Mainly Target the Monomeric State. Cell Chem Biol. 2018 Nov 15;25(11):1389-1402.e9. doi: 10.1016/j.chembiol.2018.08.005. Epub 2018 Sep 6. PubMed PMID: 30197194.

select

Biber K, Bhattacharya A, Campbell BM, Piro JR, Rohe M, Staal RGW, Talanian RV, Möller T. Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development. Front Pharmacol. 2019;10:840. doi: 10.3389/fphar.2019.00840. eCollection 2019. Review. PubMed PMID: 31507408; PubMed Central PMCID: PMC6716448.